[Translation] A Phase I/II clinical study to evaluate the safety, tolerability and preliminary efficacy of JWK001 injection in patients with neovascular age-related macular degeneration (nAMD)
评 估 JWK001 注射液在nAMD患者中单次视网膜下注射给药的安全性和耐受性 ,确定 最大耐 受剂量(MTD,如适用),或获得安全剂量范围。
[Translation] To evaluate the safety and tolerability of JWK001 injection administered as a single subretinal injection in patients with nAMD and to determine the maximum tolerated dose (MTD, if applicable), or to obtain a safe dose range.